DICE: DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from S&P Global BMI Index

DICE: DICE Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023

DICE: Eli Lilly extends tender offer for $2.4bn Dice acquisition

DICE: Lilly Announces Extension of Tender Offer to Acquire DICE

Press Release: DICE : Moore Kuehn Encourages DICE, PDCE, EMAN, and NETI Investors to Contact Law Firm

DICE: Eli Lilly acquires biotech firm Dice Therapeutics for $2.4 billion

DICE: Eli Lilly's $2.4 Billion Pending Acquisition of DICE THerapeutics